Palau Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Healthcare Times.

Press releases published on August 3, 2026

12 hours ago

Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening

Indeterminate GlobeNewswire

12 hours ago

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

Indeterminate GlobeNewswire

12 hours ago

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer

Indeterminate GlobeNewswire

12 hours ago

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Indeterminate GlobeNewswire

12 hours ago

Kaléo Announces License Agreement with Amgen for Auto-Injector Technology

Indeterminate GlobeNewswire

12 hours ago

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

Indeterminate GlobeNewswire

12 hours ago

Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

Indeterminate GlobeNewswire

12 hours ago

Neuronetics and Jorey Chernett Announce Shared Vision

Indeterminate GlobeNewswire

12 hours ago

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire

12 hours ago

Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

12 hours ago

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

12 hours ago

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Indeterminate GlobeNewswire

12 hours ago

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

Indeterminate GlobeNewswire

12 hours ago

electroCore to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Indeterminate GlobeNewswire

12 hours ago

Curium Announces Definitive Agreement to Merge with Lantheus

Indeterminate GlobeNewswire

12 hours ago

BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

12 hours ago

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

12 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

12 hours ago

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire